Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Treatment for Peritoneal Carcinomatosis From Gastric Cancer
NCT01379482Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Jan 2005
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin, oxaliplatin, fluorouracil, paclitaxel in peritoneal carcinomatosis (PC), gastric cancer (GC), sponsored by Uppsala University. Started Jan 2005; status: completed.
02
Drugs
cisplatindoxorubicinoxaliplatinfluorouracilpaclitaxel
03
Conditions
peritoneal carcinomatosis (PC)gastric cancer (GC)
Beyond the preview
Go deeper on NCT01379482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379482.